reference/9142457

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9142457

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase II\|Journal Article
endingPage	20
issn	1148-5493
issueIdentifier	1
pageRange	115-20
publicationName	European cytokine network
startingPage	115
bibliographicCitation	Braud AC, Gonzague L, Bertucci F, Genre D, Camerlo J, Gravis G, Goncalves A, Moutardier V, Viret F, Maraninchi D, Viens P. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials. Eur Cytokine Netw. 2002 Jan;13(1):115–20. PMID: 11956030.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7334f7a86e7cc72755b4407cfcfd85a3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3127-1554 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30f101ef6ad3e128e178a8fe8c446a51 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0157-0959 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74e1120efba6021b5e99b5945113ab67 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f94bb2850c602b04fb96a285fe033086 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b70683f640a1dc993ae38cf5463f66b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10dd1c3aa4b8fdf67e1d4404ccb955fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b4ab341a6c115577cf4ce895dc4c859d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c41c61b95350d73892f1ec1d7f0a8aca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7222d0bf0b8debc704763ee3b797ad1f
date	200201
identifier	https://pubmed.ncbi.nlm.nih.gov/11956030
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1153 https://portal.issn.org/resource/ISSN/1148-5493
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials
discusses	http://id.nlm.nih.gov/mesh/M0023831 http://id.nlm.nih.gov/mesh/M0025711 http://id.nlm.nih.gov/mesh/M0004505 http://id.nlm.nih.gov/mesh/M0021879
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002294Q000188 http://id.nlm.nih.gov/mesh/D002583Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009362Q000188 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D002945Q000009 http://id.nlm.nih.gov/mesh/D002945Q000008 http://id.nlm.nih.gov/mesh/D018675 http://id.nlm.nih.gov/mesh/D015474Q000009 http://id.nlm.nih.gov/mesh/D016898Q000009 http://id.nlm.nih.gov/mesh/D009364Q000188 http://id.nlm.nih.gov/mesh/D014212Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D015474Q000008 http://id.nlm.nih.gov/mesh/D016898Q000008 http://id.nlm.nih.gov/mesh/D014212Q000008 http://id.nlm.nih.gov/mesh/D016896
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7172 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282379 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282375 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7231 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129235852

Total number of triples: 61.